The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients

Anesthesiology Research and Practice

Volumn 2012, Issue , 2012, Pages

  Minou, Andrei F ^a   Dzyadzko, Alexander M ^a   Shcherba, Aliaksei E ^a   Rummo, Oleg O ^a  

^a Department of Anesthesiology and Critical Care   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; SEVOFLURANE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EXPIRATORY RESERVE VOLUME; FATTY LIVER; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 84866149199     PISSN: 16876962     EISSN: 16876970     Source Type: Journal    
DOI: 10.1155/2012/930487     Document Type: Article

References (18)

1. HHS/HRSA/HSB/DOT OPTN / SRTR. Annual Data Report 2010 54 58
2. Barshes N. R., Horwitz I. B., Franzini L., Vierling J. M., Goss J. A., Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. American Journal of Transplantation 2007 7 5 1265 1270 2-s2.0-34247377836 10.1111/j.1600-6143.2007.01758.x (Pubitemid 46643109)
3. Alkofer B., Samstein B., Guarrera J. V., Kin C., Jan D., Bellemare S., Kinkhabwala M., Brown R., Emond J. C., Renz J. F., Extended-donor criteria liver allografts. Seminars in Liver Disease 2006 26 3 221 233 2-s2.0-33746514508 10.1055/s-2006-947292 (Pubitemid 44141929)
4. Beck-Schimmer B., Breitenstein S., Urech S., Conno E. D., Wittlinger M., Puhan M., Jochum W., Spahn D. R., Graf R., Clavien P. A., A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Annals of Surgery 2008 248 6 909 916 2-s2.0-58149388742 10.1097/SLA.0b013e31818f3dda
5. Song J. C., Sun Y. M., Yang L. Q., Zhang M. Z., Lu Z. J., Yu W. F., A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia. Anesthesia and Analgesia 2010 111 4 1036 1041 2-s2.0-77957713870 10.1213/ANE.0b013e3181effda8
6. Olthoff K. M., Kulik L., Samstein B., Kaminski M., Abecassis M., Emond J., Shaked A., Christie J. D., Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transplantation 2010 16 8 943 949 2-s2.0-77955695368 10.1002/lt.22091
7. Feng S., Goodrich N. P., Bragg-Gresham J. L., Dykstra D. M., Punch J. D., DebRoy M. A., Greenstein S. M., Merion R. M., Characteristics associated with liver graft failure: the concept of a donor risk index. American Journal of Transplantation 2006 6 4 783 790 2-s2.0-33644747688 10.1111/j.1600-6143.2006. 01242.x (Pubitemid 43345017)
8. Blok J. J., Braat A. E., Adam R., Burroughs A. K., Putter H., Kooreman N. G., Rahmel A. O., Porte R. J., Rogiers X., Ringers J., Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transplantation 2012 18 1 113 120 2-s2.0-84255187742 10.1002/lt.22447
9. Kotsch K., Ulrich F., Reutzel-Selke A., Pascher A., Faber W., Warnick P., Hoffman S., Francuski M., Kunert C., Kuecuek O., Schumacher G., Wesslau C., Lun A., Kohler S., Weiss S., Tullius S. G., Neuhaus P., Pratschke J., Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation a prospective randomized controlled trial. Annals of Surgery 2008 248 6 1042 1049 2-s2.0-58149388727 10.1097/SLA.0b013e318190e70c
10. Baskin-Bey E. S., Washburn K., Feng S., Oltersdorf T., Shapiro D., Huyghe M., Burgart L., Garrity-Park M., Van Vilsteren F. G. I., Oliver L. K., Rosen C. B., Gores G. J., Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. American Journal of Transplantation 2007 7 1 218 225 2-s2.0-33845654847 10.1111/j.1600-6143.2006.01595.x (Pubitemid 44952876)
11. Bogetti D., Sankary H. N., Jarzembowski T. M., Manzelli A., Knight P. S., Thielke J., Chejfec G., Cotler S., Oberholzer J., Testa G., Benedetti E., Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clinical Transplantation 2005 19 4 507 511 2-s2.0-22244464550 10.1111/j.1399-0012.2005.00375.x (Pubitemid 40990661)
12. Peter S. D. S., Post D. J., Rodriguez-Davalos M. I., Douglas D. D., Moss A. A., Mulligan D. C., Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transplantation 2003 9 2 144 149 2-s2.0-0037320839 10.1053/jlts.2003.50018 (Pubitemid 36204565)
13. Lang J. D., Teng X., Chumley P., Crawford J. H., Isbell T. S., Chacko B. K., Liu Y., Jhala N., Crowe D. R., Smith A. B., Cross R. C., Frenette L., Kelley E. E., Wilhite D. W., Hall C. R., Page G. P., Fallon M. B., Bynon J. S., Eckhoff D. E., Patel R. P., Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. Journal of Clinical Investigation 2007 117 9 2583 2591 2-s2.0-34848888949 10.1172/JCI31892 (Pubitemid 47494359)
14. Busuttil R. W., Lipshutz G. S., Kupiec-Weglinski J. W., Ponthieux S., Gjertson D. W., Cheadle C., Watkins T., Ehrlich E., Katz E., Squiers E. C., Rabb H., Hemmerich S., RPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. American Journal of Transplantation 2011 11 4 786 797 2-s2.0-79953244190 10.1111/j.1600-6143.2011.03441.x
15. Imai M., Kon S., Inaba H., Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats. Acta Anaesthesiologica Scandinavica 1996 40 10 1242 1248 2-s2.0-0029844525 (Pubitemid 26411393)
16. Ishida H., Kadota Y., Sameshima T., Nishiyama A., Oda T., Kanmura Y., Comparison between sevoflurane and isoflurane anesthesia in pig hepatic ischemia-reperfusion injury. Journal of Anesthesia 2002 16 1 44 50 2-s2.0-0036210221 10.1007/s540-002-8093-x (Pubitemid 34285421)
17. Bedirli N., Ofluoglu E., Kerem M., Utebey G., Alper M., Yilmazer D., Bedirli A., Ozlu O., Pasaoglu H., Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesthesia and Analgesia 2008 106 3 830 837 2-s2.0-39749200170 10.1213/ane.0b013e3181616fc9 (Pubitemid 351301403)
18. Ko J. S., Gwak M. S., Choi S. J., Yang M., Kim M. J., Lee J. Y., Kim G. S., Kwon C. H. D., Joh J. W., The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors. Transplant International 2010 23 7 736 744 2-s2.0-77953183495 10.1111/j.1432-2277.2009. 01050.x